Obesity is caused by an imbalance between caloric intake and energy expenditure and accumulation of excess lipids in adipose tissues. Recent studies have demonstrated that green tea and its processed products (e.g., oolong and black tea) are introduced to exert beneficial effects on lipid metabolism. Here, we propose that fermented green tea (FGT) extract, as a novel processed green tea, exhibits antiobesity effects. FGT reduced body weight gain and fat mass without modifying food intake. mRNA expression levels of lipogenic and inflammatory genes were downregulated in white adipose tissue of FGT-administered mice. FGT treatment alleviated glucose intolerance and fatty liver symptoms, common complications of obesity. Notably, FGT restored the changes in gut microbiota composition (e.g., the Firmicutes/Bacteroidetes and Bacteroides/Prevotella ratios), which is reported to be closely related with the development of obesity and insulin resistance, induced by high-fat diets. Collectively, FGT improves obesity and its associated symptoms and modulates composition of gut microbiota; thus, it could be used as a novel dietary component to control obesity and related symptoms.
Get full access to this article
View all access options for this article.
References
1.
KopelmanPG: Obesity as a medical problem. Nature, 2000; 404:635–643.
2.
GuarnerF, MalageladaJR: Gut flora in health and disease. Lancet, 2003; 361:512–519.
3.
QinJ, LiY, CaiZ, LiS, et al.: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012; 490:55–60.
4.
SanzY, SantacruzA, GauffinP: Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc, 2010; 69:434–441.
5.
CaniPD, DelzenneNM: Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota. Curr Opin Pharmacol, 2009; 9:737–743.
6.
WuX, MaC, HanL, NawazM, et al.: Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol, 2010; 61:69–78.
7.
CaniPD, BibiloniR, KnaufC, WagetA, et al.: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 2008; 57:1470–1481.
8.
Le ChatelierE, NielsenT, QinJ, PriftiE, et al.: Richness of human gut microbiome correlates with metabolic markers. Nature, 2013; 500:541–546.
9.
BackhedF, ManchesterJK, SemenkovichCF, GordonJI: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA, 2007; 104:979–984.
10.
BackhedF, DingH, WangT, HooperLV, et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA, 2004; 101:15718–15723.
11.
LeyRE, BackhedF, TurnbaughP, LozuponeCA, et al.: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA, 2005; 102:11070–11075.
12.
TurnbaughPJ, LeyRE, MahowaldMA, MagriniV, et al.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006; 444:1027–1031.
13.
LeyRE, TurnbaughPJ, KleinS, GordonJI: Microbial ecology: Human gut microbes associated with obesity. Nature, 2006; 444:1022–1023.
14.
SchwiertzA, TarasD, SchaferK, BeijerS, et al.: Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring), 2010; 18:190–195.
15.
ParkJA, Tirupathi PichiahPB, YuJJ, OhSH, et al.: Anti-obesity effect of kimchi fermented with Weissella koreensis OK1-6 as starter in high-fat diet-induced obese C57BL/6J mice. J Appl Microbiol, 2012; 113:1507–1516.
16.
EjtahedHS, Mohtadi-NiaJ, Homayouni-RadA, NiafarM, et al.: Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci, 2011; 94:3288–3294.
YangM, WangC, ChenH: Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem, 2001; 12:14–20.
19.
LeeJE, LeeBJ, ChungJO, ShinHJ, et al.: 1 H NMR-based metabolomic characterization during green tea (Camellia sinensis) fermentation. Food Res Int, 2011; 44:597–604.
20.
JeongHW, LeeJW, KimWS, ChoeSS, et al.: A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma. Diabetes, 2011; 60:496–506.
21.
SalmonDM, FlattJP: Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes, 1985; 9:443–449.
22.
Queipo-OrtunoMI, SeoaneLM, MurriM, PardoM, et al.: Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS One, 2013; 8:e65465.
23.
DasuMR, JialalI: Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab, 2010; 300:E145–E154.
24.
TripathyD, MohantyP, DhindsaS, SyedT, et al.: Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes, 2003; 52:2882–2887.
25.
TripathyD, AljadaA, DandonaP: Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation. –to: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids. Diabetologia, 2003; 46:300–301.
26.
BodenG, ShulmanGI: Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest, 2002; 32Suppl 3:14–23.
27.
SearsCL: A dynamic partnership: Celebrating our gut flora. Anaerobe, 2005; 11:247–251.
28.
GillSR, PopM, DeboyRT, EckburgPB, et al.: Metagenomic analysis of the human distal gut microbiome. Science, 2006; 312:1355–1359.
29.
WuGD, ChenJ, HoffmannC, BittingerK, et al.: Linking long-term dietary patterns with gut microbial enterotypes. Science, 2011; 334:105–108.
30.
MorganK, UyuniA, NandgiriG, MaoL, et al.: Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol, 2008; 20:843–854.
31.
BodenG: Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep, 2006; 6:177–181.
32.
KimWS, LeeYS, ChaSH, JeongHW, et al.: Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab, 2009; 296:E812–E819.
33.
LinHZ, YangSQ, ChuckareeC, KuhajdaF, et al.: Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med, 2000; 6:998–1003.
34.
AshidaH, FuruyashikiT, NagayasuH, BesshoH, et al.: Anti-obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. Biofactors, 2004; 22:135–140.
35.
CunhaCA, LiraFS, Rosa NetoJC, PimentelGD, et al.: Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm, 2013; 2013:635470.
36.
MasterjohnC, BrunoRS: Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev, 2012; 70:41–56.
37.
ParkHJ, LeeJY, ChungMY, ParkYK, et al.: Green tea extract suppresses NF-kappa B activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr, 2012; 142:57–63.
38.
ChungMY, ParkHJ, ManautouJE, KooSI, et al.: Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem, 2012; 23:361–367.
39.
ParkHJ, DiNataleDA, ChungMY, ParkYK, et al.: Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J Nutr Biochem, 2011; 22:393–400.
40.
BrunoRS, DuganCE, SmythJA, DiNataleDA, et al.: Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr, 2008; 138:323–331.
41.
Sae-TanS, RogersCJ, LambertJD: Voluntary exercise and green tea enhance the expression of genes related to energy utilization and attenuate metabolic syndrome in high fat fed mice. Mol Nutr Food Res, 2014; 58:1156–1159.
42.
LeeHC, JennerAM, LowCS, LeeYK: Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol, 2006; 157:876–884.
43.
JinJS, TouyamaM, HisadaT, BennoY: Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol Immunol, 2012; 56:729–739.
44.
RastmaneshR: High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact, 2011; 189:1–8.
45.
NakaiM, FukuiY, AsamiS, Toyoda-OnoY, et al.: Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem, 2005; 53:4593–4598.
46.
Toyoda-OnoY, YoshimuraM, NakaiM, FukuiY, et al.: Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols. Biosci Biotechnol Biochem, 2007; 71:971–976.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
